Nana Xia

XiSi Road 20
Nantong, 226001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Exhaustion of NK cells and interferon activation in anti-MDA5+ dermatomyositis are associated and determine the development of ILD.

Exhaustion of NK cells and interferon activation in anti-MDA5+ dermatomyositis are associated and determine the development of ILD.

Journal: Frontiers in immunology

Published: September 02, 2025

Long non-coding RNA expression profiles in neutrophils revealed potential biomarker for rapidly progressive interstitial lung disease in MDA5+ dermatomyositis.

Long non-coding RNA expression profiles in neutrophils revealed potential biomarker for rapidly progressive interstitial lung disease in MDA5+ dermatomyositis.

Journal: Clinical and experimental rheumatology

Published: July 25, 2025

Quantitative proteomic analysis and replacement therapy identifies haptoglobin as a therapeutic target in a murine model of SLE-associated diffuse alveolar hemorrhage.

Quantitative proteomic analysis and replacement therapy identifies haptoglobin as a therapeutic target in a murine model of SLE-associated diffuse alveolar hemorrhage.

Journal: Frontiers in veterinary science

Published: May 23, 2024

Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.

Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.

Journal: Frontiers in immunology

Published: March 21, 2024

Efficacy and safety of abatacept for interstitial lung disease associated with antisynthetase syndrome: a case series.

Efficacy and safety of abatacept for interstitial lung disease associated with antisynthetase syndrome: a case series.

Journal: Clinical and experimental rheumatology

Published: September 30, 2022

TRAF1 knockdown alleviates palmitate-induced insulin resistance in HepG2 cells through NF-κB pathway.

TRAF1 knockdown alleviates palmitate-induced insulin resistance in HepG2 cells through NF-κB pathway.

Journal: Biochemical and biophysical research communications

Published: September 23, 2015

PRDX1 is involved in palmitate induced insulin resistance via regulating the activity of p38MAPK in HepG2 cells.

PRDX1 is involved in palmitate induced insulin resistance via regulating the activity of p38MAPK in HepG2 cells.

Journal: Biochemical and biophysical research communications

Published: July 26, 2015

KPNβ1 promotes palmitate-induced insulin resistance via NF-κB signaling in hepatocytes.

KPNβ1 promotes palmitate-induced insulin resistance via NF-κB signaling in hepatocytes.

Journal: Journal of physiology and biochemistry

Published: May 30, 2015

The Role of PTP1B O-GlcNAcylation in Hepatic Insulin Resistance.

The Role of PTP1B O-GlcNAcylation in Hepatic Insulin Resistance.

Journal: International journal of molecular sciences

Published: May 11, 2015

TAB3 involves in hepatic insulin resistance through activation of MAPK pathway.

TAB3 involves in hepatic insulin resistance through activation of MAPK pathway.

Journal: General and comparative endocrinology

Published: April 29, 2015

PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.

PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.

Journal: Biochemical and biophysical research communications

Published: April 19, 2015

TRAM1 protect HepG2 cells from palmitate induced insulin resistance through ER stress-JNK pathway.

TRAM1 protect HepG2 cells from palmitate induced insulin resistance through ER stress-JNK pathway.

Journal: Biochemical and biophysical research communications

Published: December 24, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026